Therefore, the American College of Veterinary Internal Medicine (ACVIM) consensus statement guidelines for classifying, diagnosing, and managing cardiomyopathies in cats recently recommended evaluating sarcomeric mutations of MYBPC3 before breeding to decrease this mutation in the feline population [7,8]. This evidence concerns the gene MYBPC3 and cardiomyopathy.